Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes

V. Lee Grotz, Robert R. Henry, Janet B. Mcgill, Melvin J. Prince, Harry Shamoon, J. Richard Trout, F. Xavier Pi-Sunyer

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Objective: To investigate the effect of 3-months' daily administration of high doses of sucralose, a non-nutritive sweetener, on glycemic control in subjects with type 2 diabetes. Design: A multicenter, double-blind, placebo-controlled, randomized study, consisting of a 6-week screening phase, a 13-week test phase, and a 4-week follow-up phase. Subjects/setting: Subjects with type 2 diabetes (age range 31 to 70 years) entered the test phase of this study; 128 subjects completed the study. The subjects were recruited from 5 medical centers across the United States and were, on average, obese. Intervention: Subjects were randomly assigned to receive either placebo (cellulose) capsules (n=69) or 667 mg encapsulated sucralose (n=67) daily for the 13-week test phase. All subjects blindly received placebo capsules during the last 4 weeks of the screening phase and for the entire 4-week follow-up phase. Main outcome measures: Glycated hemoglobin (HbA1c), fasting plasma glucose, and fasting serum C-peptide were measured approximately every 2 weeks to evaluate blood glucose homeostasis. Data were analyzed by analysis of variance using repeated measures. Results: There were no significant differences between the sucralose and placebo groups in HbA1c, fasting plasma glucose, or fasting serum C-peptide changes from baseline. There were no clinically meaningful differences between the groups in any safety measure. Conclusions: This study demonstrated that, similar to cellulose, sucralose consumption for 3 months at doses of 7.5 mg/kg/day, which is approximately three times the estimated maximum intake, had no effect on glucose homeostasis in individuals with type 2 diabetes. Additionally, this study showed that sucralose was as well-tolerated by the study subjects as was the placebo.

Original languageEnglish (US)
Pages (from-to)1607-1612+1711
JournalJournal of the American Dietetic Association
Volume103
Issue number12
DOIs
StatePublished - Dec 2003

Fingerprint

trichlorosucrose
sucralose
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
placebos
homeostasis
Homeostasis
Placebos
glycohemoglobin
fasting
Fasting
Glucose
glucose
C-Peptide
Cellulose
Capsules
Non-Nutritive Sweeteners
nonnutritive sweeteners
cellulose
peptides

ASJC Scopus subject areas

  • Food Science
  • Medicine(all)

Cite this

Grotz, V. L., Henry, R. R., Mcgill, J. B., Prince, M. J., Shamoon, H., Trout, J. R., & Pi-Sunyer, F. X. (2003). Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. Journal of the American Dietetic Association, 103(12), 1607-1612+1711. https://doi.org/10.1016/j.jada.2003.09.021

Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. / Grotz, V. Lee; Henry, Robert R.; Mcgill, Janet B.; Prince, Melvin J.; Shamoon, Harry; Trout, J. Richard; Pi-Sunyer, F. Xavier.

In: Journal of the American Dietetic Association, Vol. 103, No. 12, 12.2003, p. 1607-1612+1711.

Research output: Contribution to journalArticle

Grotz, VL, Henry, RR, Mcgill, JB, Prince, MJ, Shamoon, H, Trout, JR & Pi-Sunyer, FX 2003, 'Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes', Journal of the American Dietetic Association, vol. 103, no. 12, pp. 1607-1612+1711. https://doi.org/10.1016/j.jada.2003.09.021
Grotz, V. Lee ; Henry, Robert R. ; Mcgill, Janet B. ; Prince, Melvin J. ; Shamoon, Harry ; Trout, J. Richard ; Pi-Sunyer, F. Xavier. / Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. In: Journal of the American Dietetic Association. 2003 ; Vol. 103, No. 12. pp. 1607-1612+1711.
@article{37dfe02bbb314a749977d27d3d8eb52e,
title = "Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes",
abstract = "Objective: To investigate the effect of 3-months' daily administration of high doses of sucralose, a non-nutritive sweetener, on glycemic control in subjects with type 2 diabetes. Design: A multicenter, double-blind, placebo-controlled, randomized study, consisting of a 6-week screening phase, a 13-week test phase, and a 4-week follow-up phase. Subjects/setting: Subjects with type 2 diabetes (age range 31 to 70 years) entered the test phase of this study; 128 subjects completed the study. The subjects were recruited from 5 medical centers across the United States and were, on average, obese. Intervention: Subjects were randomly assigned to receive either placebo (cellulose) capsules (n=69) or 667 mg encapsulated sucralose (n=67) daily for the 13-week test phase. All subjects blindly received placebo capsules during the last 4 weeks of the screening phase and for the entire 4-week follow-up phase. Main outcome measures: Glycated hemoglobin (HbA1c), fasting plasma glucose, and fasting serum C-peptide were measured approximately every 2 weeks to evaluate blood glucose homeostasis. Data were analyzed by analysis of variance using repeated measures. Results: There were no significant differences between the sucralose and placebo groups in HbA1c, fasting plasma glucose, or fasting serum C-peptide changes from baseline. There were no clinically meaningful differences between the groups in any safety measure. Conclusions: This study demonstrated that, similar to cellulose, sucralose consumption for 3 months at doses of 7.5 mg/kg/day, which is approximately three times the estimated maximum intake, had no effect on glucose homeostasis in individuals with type 2 diabetes. Additionally, this study showed that sucralose was as well-tolerated by the study subjects as was the placebo.",
author = "Grotz, {V. Lee} and Henry, {Robert R.} and Mcgill, {Janet B.} and Prince, {Melvin J.} and Harry Shamoon and Trout, {J. Richard} and Pi-Sunyer, {F. Xavier}",
year = "2003",
month = "12",
doi = "10.1016/j.jada.2003.09.021",
language = "English (US)",
volume = "103",
pages = "1607--1612+1711",
journal = "Journal of the Academy of Nutrition and Dietetics",
issn = "2212-2672",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes

AU - Grotz, V. Lee

AU - Henry, Robert R.

AU - Mcgill, Janet B.

AU - Prince, Melvin J.

AU - Shamoon, Harry

AU - Trout, J. Richard

AU - Pi-Sunyer, F. Xavier

PY - 2003/12

Y1 - 2003/12

N2 - Objective: To investigate the effect of 3-months' daily administration of high doses of sucralose, a non-nutritive sweetener, on glycemic control in subjects with type 2 diabetes. Design: A multicenter, double-blind, placebo-controlled, randomized study, consisting of a 6-week screening phase, a 13-week test phase, and a 4-week follow-up phase. Subjects/setting: Subjects with type 2 diabetes (age range 31 to 70 years) entered the test phase of this study; 128 subjects completed the study. The subjects were recruited from 5 medical centers across the United States and were, on average, obese. Intervention: Subjects were randomly assigned to receive either placebo (cellulose) capsules (n=69) or 667 mg encapsulated sucralose (n=67) daily for the 13-week test phase. All subjects blindly received placebo capsules during the last 4 weeks of the screening phase and for the entire 4-week follow-up phase. Main outcome measures: Glycated hemoglobin (HbA1c), fasting plasma glucose, and fasting serum C-peptide were measured approximately every 2 weeks to evaluate blood glucose homeostasis. Data were analyzed by analysis of variance using repeated measures. Results: There were no significant differences between the sucralose and placebo groups in HbA1c, fasting plasma glucose, or fasting serum C-peptide changes from baseline. There were no clinically meaningful differences between the groups in any safety measure. Conclusions: This study demonstrated that, similar to cellulose, sucralose consumption for 3 months at doses of 7.5 mg/kg/day, which is approximately three times the estimated maximum intake, had no effect on glucose homeostasis in individuals with type 2 diabetes. Additionally, this study showed that sucralose was as well-tolerated by the study subjects as was the placebo.

AB - Objective: To investigate the effect of 3-months' daily administration of high doses of sucralose, a non-nutritive sweetener, on glycemic control in subjects with type 2 diabetes. Design: A multicenter, double-blind, placebo-controlled, randomized study, consisting of a 6-week screening phase, a 13-week test phase, and a 4-week follow-up phase. Subjects/setting: Subjects with type 2 diabetes (age range 31 to 70 years) entered the test phase of this study; 128 subjects completed the study. The subjects were recruited from 5 medical centers across the United States and were, on average, obese. Intervention: Subjects were randomly assigned to receive either placebo (cellulose) capsules (n=69) or 667 mg encapsulated sucralose (n=67) daily for the 13-week test phase. All subjects blindly received placebo capsules during the last 4 weeks of the screening phase and for the entire 4-week follow-up phase. Main outcome measures: Glycated hemoglobin (HbA1c), fasting plasma glucose, and fasting serum C-peptide were measured approximately every 2 weeks to evaluate blood glucose homeostasis. Data were analyzed by analysis of variance using repeated measures. Results: There were no significant differences between the sucralose and placebo groups in HbA1c, fasting plasma glucose, or fasting serum C-peptide changes from baseline. There were no clinically meaningful differences between the groups in any safety measure. Conclusions: This study demonstrated that, similar to cellulose, sucralose consumption for 3 months at doses of 7.5 mg/kg/day, which is approximately three times the estimated maximum intake, had no effect on glucose homeostasis in individuals with type 2 diabetes. Additionally, this study showed that sucralose was as well-tolerated by the study subjects as was the placebo.

UR - http://www.scopus.com/inward/record.url?scp=0347361497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347361497&partnerID=8YFLogxK

U2 - 10.1016/j.jada.2003.09.021

DO - 10.1016/j.jada.2003.09.021

M3 - Article

VL - 103

SP - 1607-1612+1711

JO - Journal of the Academy of Nutrition and Dietetics

JF - Journal of the Academy of Nutrition and Dietetics

SN - 2212-2672

IS - 12

ER -